SEAN BRYNJELSEN - President & CEO, Director, 10%+ Owner at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director, 10%+ Owner
Issuer Symbol
ETON on Nasdaq
All Insider Reports
All Insider Reports

SEAN BRYNJELSEN - trading volume in the past year for Eton Pharmaceuticals, Inc.

Holdings reported by SEAN BRYNJELSEN for Eton Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,889,266 $44,465,803 $15.39 01 Jan 2026 Direct
Restricted Stock Units 3,147,829 $574,693 $7.98 12 Jan 2026 Direct Common Stock
Employee Stock Option (Right to Buy) 3,047,312 12 Jan 2026 Direct Common Stock

Transactions reported by SEAN BRYNJELSEN for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.